| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
1,960.00
|
|
Change (%)
|
10.00 (0.51%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
1,946.00
-
1,965.50
|
|
52-Week Range (RS)
|
1,547.25
-
2,047.55
|
|
Beta (1 Year)
|
0.47
|
|
|
|
|
|
| Index Details |
| BSE SENSEX, BSE 100, BSE 500, BSE 200, BSE HC, BSE DOLLEX |
| News |
|
Corporate Details |
| Sun Pharmaceutical Industries consolidated net profit rises 27.04% in the June 2026 quarter |
| Sun Pharma Q1 PAT climbs 27% YoY to Rs 2,895 cr; India business drives growth |
| Sun Pharmaceutical Industries Ltd spurts 1.6%, up for five straight sessions |
| Sun Pharma receives Organon shareholders approval for merger |
| Sun Pharma receives approval to market semaglutide injection in South Africa |
| Sun Pharma gets nod for Semaglutide injection in South Africa |
| Barometers trade higher; private bank shares jump |
| Sun Pharmaceuticals Industries announces board meeting date |
| Sun Pharmaceutical Industries Ltd spurts 0.07%, up for five straight sessions |
| Sun Pharmaceutical Industries Ltd spurts 2.14% |
|
|
|
| Incoporation Year : 1993 |
| Chairman : Dilip S Shanghvi |
| Ownership Group : Sun Pharma |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Registered Office |
Sun Pharmaceutical Industries Ltd
Sun Pharma Advanced Res.Centre,
Tandalja,
Vadodara,
Gujarat-390020 |
Phone:91-265-6615500
Fax:91-265-2354897 |
| E-Mail : secretarial@sunpharma.com |
| URL : http://www.sunpharma.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
28-Jul-2026 |
1977.20 |
-0.87 |
| 1Month |
06-Jul-2026 |
1913.05 |
2.45 |
| 3Month |
04-May-2026 |
1824.10 |
7.45 |
| 6Month |
04-Feb-2026 |
1704.00 |
15.02 |
| 1Year |
04-Aug-2025 |
1641.00 |
19.44 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| SBI Nifty 50 ETF |
1.80 |
3777.97 |
| ICICI Pru Value Fund |
4.79 |
2881.80 |
| SBI BSE SENSEX ETF |
2.21 |
2638.87 |
| ICICI Pru Large Cap Fund |
2.52 |
1997.52 |
| ICICI Pru Equity & Debt Fund |
3.60 |
1854.57 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Cipla Ltd |
1,450.00 |
-1.29 |
1,672.20 |
1,165.55 |
117,137.57 |
| Zydus Lifesciences Ltd |
1,118.50 |
0.20 |
1,181.00 |
835.85 |
111,570.80 |
| Lupin Ltd |
2,376.00 |
0.00 |
2,530.00 |
1,838.65 |
108,638.45 |
| Mankind Pharma Ltd |
2,461.00 |
-0.54 |
2,670.00 |
1,909.90 |
101,638.31 |
| Laurus Labs Ltd |
1,835.50 |
1.35 |
1,840.45 |
810.75 |
99,174.31 |
|
|
|
|